Predictive performance of peritoneal fluid in the pouch of Douglas measured five days after oocyte pick-up in predicting severe late-onset OHSS: A secondary analysis of a randomized trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 837 KB, PDF-dokument

  • A. G. Grynnerup
  • K. Løssl
  • M. Toftager
  • J. W. Bogstad
  • L. Prætorius
  • A. Zedeler
  • Pinborg, Anja

Objectives: To investigate if the amount of peritoneal fluid (PF) in the Pouch of Douglas at oocyte pick-up (OPU) or OPU + 5 days predict severe late-onset ovarian hyperstimulation syndrome (OHSS) in women undergoing ovarian stimulation for assisted reproductive technology (ART). Study design: A secondary analysis of a dual-centre RCT on 1050 women referred for their first ART treatment in two public fertility clinics in Denmark and randomized 1:1 to GnRH-antagonist or GnRH-agonist protocol. All women from the two arms who were examined on day of OPU and OPU + 5 days were included in this study (n = 940). The ability of PF in the pouch of Douglas to predict severe late-onset OHSS was assessed by multivariate logistic regression analyses and receiver operator characteristics (ROC) curve analyses and compared with other known predictors of OHSS. The final models were cross-validated by the leave-one-out method to assess the models’ generalizability. Results: A total of 28 (3%) women developed severe late-onset OHSS. PF in the pouch of Douglas measured on OPU + 5 days predicted severe late-onset OHSS. The optimal cut-off value was 17.5 mm at OPU + 5 days with a 61% sensitivity and 71% specificity (Area under the curve = 0.70 95% CI 0.61–0.80). PF on the day of OPU was not predictive of late on-set OHSS as the adjusted multivariate logistic regression analyses showed insignificant results. Conclusion: Although PF in the pouch of Douglas could predict late-onset severe OHSS, the low sensitivity underlines that it is not useful as a sole marker to decide whether to perform blastocyst transfer or to use a freeze-all strategy.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Vol/bind274
Sider (fra-til)83-87
Antal sider5
ISSN0301-2115
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
The authors thank the participating women; all doctors, study nurses, nurses, and laboratory staff employed at the Fertility Clinic at Hvidovre Hospital and Dronninglund Fertility Clinic. For the primary RCT, an unrestricted research grant was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (MSD).

Funding Information:
The authors thank the participating women; all doctors, study nurses, nurses, and laboratory staff employed at the Fertility Clinic at Hvidovre Hospital and Dronninglund Fertility Clinic. For the primary RCT, an unrestricted research grant was funded by Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc. Kenilworth, NJ, USA (MSD).

Publisher Copyright:
© 2022 The Authors

ID: 313701266